Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

One-year clinical trial data for the next-generation, investigational, Sphere-360TM single-shot PFA catheter show impressive safety, perf ...

The power of a pope, it is said these days, is seen on the day of his funeral: with the 'greats of the earth' (a terrible expression...) competing to attend. But this belief is a cynicism, ...

The second is the paroxysmal phase, characterized by a sudden ... This may be the only symptom in some infants, who may not develop the signature cough. Sudden fits or attacks, known as paroxysms, of ...

The cardiovascular system, the human body’s circulatory system, is a vital network of organs and tissues such as the blood, heart, and blood vessels responsible for transporting blood. The circulatory ...

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.

The oral complement inhibitor is already used to treat primary immunoglobulin A nephropathy (IgAN) and paroxysmal nocturnal haemoglobinuria (PNH), with sales reaching $129 million in for full-year ...

Technically known as paroxysmal respiration ... Reverse sneezes happen when a dog inhales sharply. The attacks usually last a few seconds, but they can be startling if you’re not expecting ...

we tried nVNS in eight chronic paroxysmal hemicrania (CPH) patients who were intolerant of indomethacin. Patients were diagnosed as CPH based on ICHD-3 beta criteria.1 At initial presentation, some ...

Patients undergoing atrial fibrillation (AFib) ablation who were not properly anticoagulated and did not undergo preprocedural transesophageal echocardiogram (TEE) were significantly more likely to ...

RLYB212 is a human monoclonal antibody the company was developing to treat fetal and neonatal alloimmune thrombocytopenia (FNAIT), a rare bleeding disorder in which a mother’s immune system attacks a ...

Both biosimilars are approved to treat patients with several rare diseases, including paroxysmal nocturnal hemoglobinuria ... leading the body to attack its own red blood cells. Atypical hemolytic ...